From the Guidelines
Hypertension management should be initiated when blood pressure consistently exceeds 130/80 mmHg, with a goal of reducing it below this threshold, as recommended by the 2022 World Health Organization guideline 1.
Key Recommendations
- First-line medications include thiazide diuretics, ACE inhibitors, ARBs, or calcium channel blockers, with specific dosages such as hydrochlorothiazide 12.5-25mg daily, lisinopril 10-40mg daily, losartan 50-100mg daily, or amlodipine 5-10mg daily.
- Lifestyle modifications are essential for all patients, including:
- Reducing sodium intake to less than 2,300mg daily
- Regular physical activity, such as 150 minutes of moderate exercise weekly
- Limiting alcohol consumption
- Maintaining a healthy weight
- Following the DASH diet rich in fruits, vegetables, and low-fat dairy
Treatment Approach
- For patients with stage 2 hypertension (≥140/90 mmHg), combination therapy with two medications from different classes is often needed initially.
- Blood pressure should be monitored regularly, with home measurements providing valuable data between office visits.
- Treatment adjustments should be made every 2-4 weeks until target blood pressure is achieved.
Rationale
The 2022 World Health Organization guideline 1 provides the most current and relevant evidence-based guidance for pharmacological treatment of hypertension in non-pregnant adults, with a particular focus on practice in middle- and low-income countries. The guideline emphasizes the importance of lifestyle modifications and first-line medications in managing hypertension, and provides recommendations for treatment goals, initial and longer-term visit intervals, and the best use of health care workers for management of hypertension. The American College of Cardiology/American Heart Association guideline 1 and the U.S. Department of Veterans Affairs/U.S. Department of Defense clinical practice guideline 1 also support these recommendations, highlighting the importance of early detection, diagnosis, and management of hypertension to reduce the risk of cardiovascular events, stroke, and kidney disease.
From the FDA Drug Label
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC)
The guidelines for managing Hypertension (High Blood Pressure) include:
- Comprehensive cardiovascular risk management
- Lipid control
- Diabetes management
- Antithrombotic therapy
- Smoking cessation
- Exercise
- Limited sodium intake
- Following published guidelines, such as those of the National High Blood Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC) 2 3
From the Research
Guidelines for Managing Hypertension
The guidelines for managing hypertension emphasize the importance of lifestyle modifications as the first-line treatment. The following are some of the key recommendations:
- Diet adaptation, including low sodium and high potassium intake, is recommended by all guidelines 4, 5
- Physical exercise and weight reduction are also recommended as part of lifestyle modifications 4, 5, 6, 7
- Alcohol restriction and smoking cessation are also emphasized as important lifestyle interventions 4, 5, 7
- The Dietary Approaches to Stop Hypertension (DASH) diet may be considered the most effective treatment for reducing blood pressure 4
Lifestyle Modifications
Lifestyle modifications are crucial in the treatment of hypertension and should be recommended to most hypertensive patients. These modifications can:
- Reduce blood pressure and enhance the effects of antihypertensive therapy 4, 5, 6
- Minimize the number and dose of medications required 7
- Improve biomarkers of cardiovascular risk 6
Medication Therapy
When medication is required, the following are recommended as first-line therapies:
- Thiazide or thiazide-like diuretics 5, 8
- Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers 5, 8
- Calcium channel blockers 5, 8
- The selection of additional antihypertensive therapies should be based on the presence of concomitant cardiovascular and metabolic conditions as well as patient-specific factors such as race 8
Resistant Hypertension
For patients with resistant hypertension, lifestyle modifications can still be effective in reducing blood pressure and improving cardiovascular risk biomarkers 6. These modifications can be added to optimized medical therapy to achieve better outcomes.